PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:12 AM ET

Sponsor Check › Person

SG
No photo found yet (own website and image search run after this page is viewed)

Steve Gorlin

Named as an officer, director or promoter on SEC Form D filings · FL, GA, CA, CO, NJ, UT, MN, NV, TX · May 1, 2009 → Sep 21, 2016

15deals (issuers)
$681.9Mreported sold
472investors
49Form D filings
2009–2016years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Steve Gorlin is listed as an executive officer and director on 49 SEC Form D filings by 15 issuers between May 2009 and Feb 2026. Largest by amount reported sold: ImmunityBio, Inc. (San Diego, CA — biotechnology — 2015; $470M reported sold to 48 investors), Vavotar Life Sciences LLC (Aspen, CO — other health care — 2016–2019; $80.8M reported sold to 31 investors), CoRegen, Inc. (Houston, TX — biotechnology — 2024–2026; $62.6M reported sold to 31 investors), POLARITYTE, INC. (Salt Lake City, UT — biotechnology — 2017; $17.8M reported sold to 28 investors), SmartPharm Therapeutics, Inc. (Aspen, CO — other health care — 2019; $10.5M reported sold to 27 investors) and 10 more (all listed below).

What this means That is a lot of deals — 15 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $681.9M sold in total.

Listed alongside Charles Farrahar (21 shared filings), John Thomas (13 shared filings), Charles E. Koob (9 shared filings), Parker H. Petit (7 shared filings), Bruce Hack (6 shared filings) and 113 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Steve. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 2 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 49 public filings for Steve Gorlin and found 23 differences, 7 worth asking the sponsor about: 4 regulator actions name the subject or team members; Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Steve Gorlin has not run yet — it is #44,170 of 49,132 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 1 closed (disposition not in docket feed), 1 judgment

United Community Bank v. Gorlin Aviation, LLC closed
District Court, N.D. Georgia · No. 2:17-cv-00183 · Filed Sep 12, 2017 · Closed Feb 23, 2018 · Nature of suit: 863 D.I.W.C. / D.I.W.W.
Role of Gorlin Aviation, LLC: Defendant · Outcome: Terminated 2018-02-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 4 federal dockets); surname only in the caption; court in the person's filing state (GA)
GORLIN v. BOND RICHMAN & CO judgment
District Court, S.D. New York · No. · Filed Apr 12, 1984 · Closed Feb 14, 1989 · Nature of suit: 850 Securities, Commodities, Exchange
Role of GORLIN: Plaintiff · Outcome: Terminated 1989-02-14 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for defendant Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 4 federal dockets); surname only in the caption; court in NY (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Steve Gorlin..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Jonathan M. Gorlin and Portfolio Recovery Associtaes, LLC closed
United States Bankruptcy Court, S.D. Texas · No. 05-47765 · Filed Oct 7, 2005 · Closed Mar 24, 2011
Role of Jonathan M. Gorlin and Portfolio Recovery Associtaes, LLC: Debtor · Outcome: Case closed 2011-03-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 4 federal dockets); different first name (jonathan); court in the person's filing state (TX)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

23 differences found between the filings for Steve Gorlin — 7 worth asking about (compared 49 filings on Oct 24, 2026)

Worth asking · Jan 11, 2012 – Aug 21, 2023

4 regulator actions name the subject or team members

Regulator action naming a team member: Michael J. Senken (Aug 21, 2023) · Regulator action naming a team member: Terren S. Peizer and Acuitas Group Holdings, LLC (Mar 8, 2023) · Regulator action naming a team member: MiMedx Group, Inc., Parker H. Petit, William C. Taylor, and Michael J. Senken (Nov 26, 2019) · Regulator action naming a team member: Earl C. Arrowood and Parker H. "Pete" Petit (Jan 11, 2012)

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Michael J. Senken ↗Michael J. Senken — PartnerFacts page ↗Terren S. Peizer and Acuitas Group Holdings, LLC ↗Terren Peizer — PartnerFacts page ↗
Sources
Note · Sep 24, 2003 – Jun 6, 2023

5 bankruptcy cases name the subject or team members

Bankruptcy case: PolarityTE, Inc., (a Nevada Corporation) (PTE-NV) — filed Jun 6, 2023 · Bankruptcy case: PolarityTE, Inc. — filed Jun 6, 2023 · Bankruptcy case: DemeRx, Inc. — filed Apr 9, 2018 · Bankruptcy case: GO GLOBAL, INC. v. ROGICH — filed Nov 26, 2014 · Bankruptcy case: ALADDIN GAMING CREDITORS' TRUST v. THE ROGICH COMMUNICATIONS GROUP, INC. — filed Sep 24, 2003

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Utah ↗POLARITYTE, INC. — PartnerFacts page ↗Docket · United States Bankruptcy Court, D. Utah ↗Docket · United States Bankruptcy Court, S.D. Florida. ↗
Sources
Worth asking · May 1, 2009 – Nov 19, 2009

Amount sold went down between filings — MIMEDX GROUP, INC.

The May 1, 2009 filing says $1,420,000 sold; the Nov 19, 2009 Form D says $675,000 sold — $745,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · May 1, 2009 ↗Form D (later) · Nov 19, 2009 ↗MIMEDX GROUP, INC. — PartnerFacts page ↗
Sources
Worth asking · May 1, 2009 – Nov 19, 2009

Investor count went down between filings — MIMEDX GROUP, INC.

The May 1, 2009 filing reports 13 investors; the Nov 19, 2009 Form D reports 6 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · May 1, 2009 ↗Form D (later) · Nov 19, 2009 ↗MIMEDX GROUP, INC. — PartnerFacts page ↗
Sources
Worth asking · Apr 30, 2015

26% of the money raised went to insiders — Ontrak, Inc.

The Apr 30, 2015 Form D reports $2,121,212 sold and $560,000 of the proceeds used for payments to officers, directors or promoters. Issuer's note: "Repayment of outstanding indebtedness to a person named in Item 3.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Apr 30, 2015 ↗Ontrak, Inc. — PartnerFacts page ↗
Sources
Note · Aug 21, 2009

17% of the money raised went to insiders — Celnyx, Inc.

The Aug 21, 2009 Form D reports $3,000,000 sold and $500,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Aug 21, 2009 ↗Celnyx, Inc. — PartnerFacts page ↗
Sources
Worth asking · May 8, 2015 – Jul 13, 2023

Steve Gorlin appears on 5 deals that stopped filing before reaching their target

Vicapsys Life Sciences, Inc. (last filing Jul 13, 2023; $470,000 sold of $6,000,000); Rion LLC (last filing Nov 3, 2020; $5,160,003 sold of $20,250,000); AperiSys, Inc. (last filing Jan 18, 2019; $3,470,000 sold of $20,700,000); Genomic Cancer Institute, Inc. (last filing Jan 8, 2016; $0 sold of $1,499,999); DemeRx, Inc. (last filing May 8, 2015; $5,137,028 sold of $15,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Vicapsys Life Sciences, Inc. — PartnerFacts page ↗Rion LLC — PartnerFacts page ↗AperiSys, Inc. — PartnerFacts page ↗Genomic Cancer Institute, Inc. — PartnerFacts page ↗
Sources
Worth asking · Aug 21, 2009 – Jan 18, 2019

5 paid sellers are listed without a CRD number

Paid seller listed without a CRD number: Finsoft Consultants, Inc. — Vavotar Life Sciences LLC · Paid seller listed without a CRD number: Virginia Dadey — Vavotar Life Sciences LLC · Paid seller listed without a CRD number: Ashley Johnson — Vavotar Life Sciences LLC · Paid seller listed without a CRD number: Lyons Capital, LLC — MIMEDX GROUP, INC. · Paid seller listed without a CRD number: Jason Lyons — Celnyx, Inc.

What this means Without a CRD number we cannot look a seller up on BrokerCheck. Ask who they are and whether they are registered.

Form D · Jan 18, 2019 ↗BrokerCheck search: Finsoft Consultants, Inc. ↗Vavotar Life Sciences LLC — PartnerFacts page ↗BrokerCheck search: Virginia Dadey ↗
Sources
Worth asking · Apr 7, 2009 – Feb 26, 2026

23 Form Ds were filed more than 15 days after the first sale

Form D filed 121 days after the first sale — CoRegen, Inc. · Form D filed 577 days after the first sale — CoRegen, Inc. · Form D filed 440 days after the first sale — SmartPharm Therapeutics, Inc. · Form D filed 74 days after the first sale — Vavotar Life Sciences LLC · Form D filed 71 days after the first sale — AperiSys, Inc. · and 18 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Feb 26, 2026 ↗CoRegen, Inc. — PartnerFacts page ↗Form D · Mar 8, 2024 ↗Form D · Apr 8, 2019 ↗
Sources
Note · Apr 7, 2009 – Feb 22, 2024

16 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — CoRegen, Inc. (latest filing Feb 22, 2024) · No amendment in the last 12 months on an offering that may still be open — AperiSys, Inc. (latest filing Jan 18, 2019) · No amendment in the last 12 months on an offering that may still be open — Vicapsys Life Sciences, Inc. (latest filing Feb 16, 2018) · No amendment in the last 12 months on an offering that may still be open — Vicapsys Life Sciences, Inc. (latest filing Jan 8, 2018) · No amendment in the last 12 months on an offering that may still be open — Rion LLC (latest filing Jun 29, 2017) · and 11 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Feb 22, 2024 ↗CoRegen, Inc. — PartnerFacts page ↗Form D/A · Jan 18, 2019 ↗AperiSys, Inc. — PartnerFacts page ↗
Sources
Note · Feb 28, 2025 – May 22, 2025

Steve Gorlin's role changed at CoRegen, Inc.: director → executive officer, director

The Feb 28, 2025 filing lists Steve Gorlin as director; the May 22, 2025 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 28, 2025 ↗Form D · May 22, 2025 ↗Steve Gorlin — PartnerFacts page ↗CoRegen, Inc. — PartnerFacts page ↗
Sources
Note · Mar 8, 2024 – Feb 28, 2025

Steve Gorlin's role changed at CoRegen, Inc.: executive officer, director → director

The Mar 8, 2024 filing lists Steve Gorlin as executive officer, director; the Feb 28, 2025 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Mar 8, 2024 ↗Form D · Feb 28, 2025 ↗Steve Gorlin — PartnerFacts page ↗CoRegen, Inc. — PartnerFacts page ↗
Sources
Note · Mar 1, 2013 – May 8, 2015

Steve Gorlin's role changed at DemeRx, Inc.: executive officer, director → director

The Mar 1, 2013 filing lists Steve Gorlin as executive officer, director; the May 8, 2015 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Mar 1, 2013 ↗Form D · May 8, 2015 ↗Steve Gorlin — PartnerFacts page ↗DemeRx, Inc. — PartnerFacts page ↗
Sources
Note · Jun 24, 2015 – Jul 17, 2015

Offering amount changed between filings — ImmunityBio, Inc.

The Jun 24, 2015 filing says $71,004,041 offered; the Jul 17, 2015 Form D/A says $78,004,041.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 24, 2015 ↗Form D/A (later) · Jul 17, 2015 ↗ImmunityBio, Inc. — PartnerFacts page ↗
Sources
Note · Sep 4, 2012 – Feb 27, 2013

Offering amount changed between filings — DemeRx, Inc.

The Sep 4, 2012 filing says $8,250,000 offered; the Feb 27, 2013 Form D/A says $11,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Sep 4, 2012 ↗Form D/A (later) · Feb 27, 2013 ↗DemeRx, Inc. — PartnerFacts page ↗
Sources
Note · May 1, 2009 – Nov 19, 2009

Offering amount changed between filings — MIMEDX GROUP, INC.

The May 1, 2009 filing says $4,025,000 offered; the Nov 19, 2009 Form D says $5,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · May 1, 2009 ↗Form D (later) · Nov 19, 2009 ↗MIMEDX GROUP, INC. — PartnerFacts page ↗
Sources
Note · Apr 10, 2017 – Sep 26, 2017

Industry group changed between filings — POLARITYTE, INC.

"Other" (Apr 10, 2017); then "Biotechnology" (Sep 26, 2017).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 10, 2017 ↗Form D · Sep 26, 2017 ↗POLARITYTE, INC. — PartnerFacts page ↗
Sources
Note · May 3, 2010 – Sep 4, 2012

Industry group changed between filings — DemeRx, Inc.

"Biotechnology" (May 3, 2010 to Jun 21, 2010); then "Pharmaceuticals" (Sep 4, 2012 to May 8, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 3, 2010 ↗Form D · Sep 4, 2012 ↗DemeRx, Inc. — PartnerFacts page ↗
Sources
Note · Dec 31, 2014 – Apr 30, 2015

Reported revenue range changed between filings — Ontrak, Inc.

"$1 - $1,000,000" (Dec 31, 2014); then "$1,000,001 - $5,000,000" (Apr 30, 2015).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Dec 31, 2014 ↗Form D · Apr 30, 2015 ↗Ontrak, Inc. — PartnerFacts page ↗
Sources
Note · May 1, 2009 – Nov 29, 2010

Reported revenue range changed between filings — MIMEDX GROUP, INC.

"No Revenues" (May 1, 2009); then "$1 - $1,000,000" (Nov 29, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · May 1, 2009 ↗Form D · Nov 29, 2010 ↗MIMEDX GROUP, INC. — PartnerFacts page ↗
Sources
Note · Jan 31, 2012

Same name, different state: "Steve Gorlin" (NC) is a separate record

This page covers filings where the address state is FL or GA or CA or CO or NJ or UT or MN or NV or TX. A separate record, "Steve Gorlin" with address state NC, is listed on 1 filing — most recently by DARA BioSciences, Inc. (Jan 31, 2012). Both records have filings in the same period (Jan 31, 2012).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Steve Gorlin (NC) — PartnerFacts page ↗Form D · Jan 31, 2012 ↗DARA BioSciences, Inc. — PartnerFacts page ↗Steve Gorlin (FL,GA,CA,CO,NJ,UT,MN,NV,TX) — this page ↗
Sources
Note · May 1, 2009 – Feb 26, 2026

10 address changes between filings

Address moved from Aspen, CO to Houston, TX — CoRegen, Inc. · Address moved from Cumming, GA to Rochester, MN — Rion LLC · Address moved from Culver City, CA to Aspen, CO — Vavotar Life Sciences LLC · Address moved from Destin, FL to Aspen, CO — AperiSys, Inc. · Address moved from South Plainfield, NJ to Salt Lake City, UT — POLARITYTE, INC. · and 5 more

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · May 22, 2025 ↗Form D · Feb 26, 2026 ↗CoRegen, Inc. — PartnerFacts page ↗Form D · Jun 29, 2017 ↗
Sources
Note · May 1, 2009 – Feb 26, 2026

Steve Gorlin is listed with 9 different address states: FL, GA, CA, CO, NJ, UT, MN, NV, TX

FL on 17 filings (May 1, 2009 to Sep 21, 2016); GA on 7 filings (Nov 19, 2009 to Feb 16, 2018); CA on 7 filings (Dec 31, 2014 to Jan 5, 2017); CO on 13 filings (May 16, 2016 to May 22, 2025); NJ on 1 filing (Apr 10, 2017); UT on 1 filing (Sep 26, 2017); MN on 1 filing (Nov 3, 2020); NV on 1 filing (Jul 25, 2022); TX on 1 filing (Feb 26, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · May 1, 2009 ↗Form D · Nov 19, 2009 ↗Form D · Dec 31, 2014 ↗Form D · May 16, 2016 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

12 of 40 offerings report sales commissions totalling $8,480,764; 3 report finder's fees totalling $282,000; 6 report proceeds to related persons totalling $3,073,833. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 26, 2026 D
CoRegen, Inc.
File 021-574816
$540,000 (est.)$0$0Stonehaven, LLC BrokerCheck CRD 118913 ↗
via Terrance Joseph Philips (CRD 8015702 ↗)

Stonehaven, LLC BrokerCheck CRD 118913 ↗
via Marc Christopher Rucinski (CRD 4543011 ↗)
EDGAR ↗
May 22, 2025 D
CoRegen, Inc.
File 021-546928
$4,130,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗
Feb 28, 2025 D
CoRegen, Inc.
File 021-539551
$1,400,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗
Feb 28, 2025 D
CoRegen, Inc.
File 021-539577
$700,000 (est.)$0$0M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗
Mar 8, 2024 D
CoRegen, Inc.
File 021-507023
$84,000$0$1,013,833
Director fees and executive compensation payments (includes amounts paid to a former director)
M M Dillon & Co. LLC BrokerCheck CRD 19878 ↗
via Elena Ulansky (CRD 7654267 ↗)

M M Dillion & Co. LLC BrokerCheck CRD 19878 ↗
via Jeff Robert Swarz (CRD 1563420 ↗)
EDGAR ↗
Feb 22, 2024 D
CoRegen, Inc.
File 021-505805
$0$0$0None listed on this filingEDGAR ↗
Jul 25, 2022 D
BIOVIE INC.
File 021-453512
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2020 D
Rion LLC
File 021-379530
$0$0$0None listed on this filingEDGAR ↗
Apr 8, 2019 D
SmartPharm Therapeutics, Inc.
File 021-336656
$0$0$0None listed on this filingEDGAR ↗
Jan 18, 2019 D/A
AperiSys, Inc.
File 021-330270
$68,000$0$0LaidLaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗EDGAR ↗
Jan 18, 2019 D
Vavotar Life Sciences LLC
File 021-330875
$156,000 (est.)$0$0Finsoft Consultants, Inc. no CRD number reported
Virginia Dadey no CRD number reported
Ashley Johnson no CRD number reported		EDGAR ↗
Feb 16, 2018 D
Vicapsys Life Sciences, Inc.
File 021-305893
$600,000$0$0Titan Securities BrokerCheck CRD 131392 ↗EDGAR ↗
Jan 8, 2018 D
Vicapsys Life Sciences, Inc.
File 021-302620
$0$0$0None listed on this filingEDGAR ↗
Sep 26, 2017 D
POLARITYTE, INC.
File 021-295429
$0$0$0None listed on this filingEDGAR ↗
Jun 29, 2017 D
Rion LLC
File 021-289735
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2017 D
POLARITYTE, INC.
File 021-284457
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2017 D
Ontrak, Inc.
File 021-277748
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2016 D
Vavotar Life Sciences LLC
File 021-271170
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2016 D
Vavotar Life Sciences LLC
File 021-271131
$0$0$0None listed on this filingEDGAR ↗
Sep 21, 2016 D
Vavotar Life Sciences LLC
File 021-271060
$0$0$0None listed on this filingEDGAR ↗
May 16, 2016 D
Vavotar Life Sciences LLC
File 021-263277
$0$0$0None listed on this filingEDGAR ↗
May 3, 2016 D
H-CYTE, INC.
File 021-262510
$167,764$0$0Laidlaw and Company (UK) Ltd. BrokerCheck CRD 119037 ↗EDGAR ↗
Jan 8, 2016 D
Genomic Cancer Institute, Inc.
File 021-254824
$0$40,000 (est.)$800,000 (est.)
This amount represents 1 year of salaries to executives.
None listed on this filingEDGAR ↗
Jan 5, 2016 D
Vavotar Life Sciences LLC
File 021-254485
$0$0$0None listed on this filingEDGAR ↗
Dec 7, 2015 D/A
AperiSys, Inc.
File 021-252410
$0$0$0None listed on this filingEDGAR ↗
Dec 7, 2015 D/A
AperiSys, Inc.
File 021-252411
$0$0$0None listed on this filingEDGAR ↗
Dec 7, 2015 D/A
AperiSys, Inc.
File 021-252413
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2015 D
Ontrak, Inc.
File 021-249410
$0$0$0None listed on this filingEDGAR ↗
Aug 5, 2015 D
ImmunityBio, Inc.
File 021-245114
$0$0$0None listed on this filingEDGAR ↗
Jul 17, 2015 D/A
ImmunityBio, Inc.
File 021-242356
$0$0$0None listed on this filingEDGAR ↗
May 8, 2015 D
DemeRx, Inc.
File 021-239478
$0$0$0None listed on this filingEDGAR ↗
Apr 30, 2015 D
Ontrak, Inc.
File 021-238927
$185,000$0$560,000
Repayment of outstanding indebtedness to a person named in Item 3.
Chardan Capital Markets LLC BrokerCheck CRD 120128 ↗EDGAR ↗
Apr 7, 2015 D
H-CYTE, INC.
File 021-237425
$0$0$0None listed on this filingEDGAR ↗
Dec 31, 2014 D
Ontrak, Inc.
File 021-231172
$50,000 (est.)$0$0Chardan Capital Markets LLC BrokerCheck CRD 120128 ↗EDGAR ↗
Mar 1, 2013 D/A
DemeRx, Inc.
File 021-183624
$400,000 (est.)$0$100,000 (est.)
Reimbursement for offering expenses
GILFORD SECURITIES INCORPORATED BrokerCheck CRD 8076 ↗EDGAR ↗
Nov 29, 2010 D
MIMEDX GROUP, INC.
File 021-151121
$0$0$0None listed on this filingEDGAR ↗
Jun 21, 2010 D
DemeRx, Inc.
File 021-143781
$0$0$100,000 (est.)
Reimbursement for offering expenses
None listed on this filingEDGAR ↗
May 3, 2010 D
DemeRx, Inc.
File 021-141447
$0$0$0None listed on this filingEDGAR ↗
Nov 19, 2009 D
MIMEDX GROUP, INC.
File 021-114396
$0 (est.)$42,000 (est.)$0Lyons Capital, LLC no CRD number reportedEDGAR ↗
Aug 21, 2009 D
Celnyx, Inc.
File 021-133856
$0$200,000$500,000 (est.)Jason Lyons no CRD number reportedEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 15

Every issuer that named Steve Gorlin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

C
Biotechnology

CoRegen, Inc.

Houston, TX · Feb 22, 2024 → Feb 26, 2026 · 6 filings
  • Feb 26, 2026 · D · $13,500,000 sold of $13,500,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (President and Vice Chairman of the Board) EDGAR ↗
  • May 22, 2025 · D · $62,640,000 sold of $62,640,000 · 8 investors · min. $25,000 · role: Executive Officer, Director (President of the Issuer) EDGAR ↗
  • Feb 28, 2025 · D · $10,000,002 sold of $10,000,002 · 1 investors · min. $25,000 · role: Director EDGAR ↗
  • Feb 28, 2025 · D · $20,750,000 sold of $20,750,000 · 7 investors · min. $25,000 · role: Director EDGAR ↗
  • Mar 8, 2024 · D · $12,870,000 sold of $12,870,000 · 31 investors · min. $25,000 · role: Executive Officer, Director (Chief Executive Officer of the Issuer) EDGAR ↗
  • Feb 22, 2024 · D · $14,500,000 sold of Indefinite · 1 investors · min. $14,500,000 · role: Executive Officer, Director (Chief Executive Officer of the Issuer) EDGAR ↗

Raised $62.6M from 31 investors (100% of the $13.5M target) as of the latest filing. Steve is listed as executive officer, director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Biotechnology

BIOVIE INC.

Carson City, NV · Jul 25, 2022
  • Jul 25, 2022 · D · $6,000,000 sold of $6,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 20 investors (100% of the $6M target) as of the latest filing. Steve is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

R
Biotechnology

Rion LLC

Rochester, MN · Jun 29, 2017 → Nov 3, 2020 · 2 filings
  • Nov 3, 2020 · D · $0 sold of $20,250,000 · 0 investors · min. $1,000,000 · role: Director (Vice Chairman) EDGAR ↗
  • Jun 29, 2017 · D · $5,160,003 sold of $9,280,000 · 22 investors · min. $50,000 · role: Director (Governor and Vice Chairman) EDGAR ↗

Raised $5.16M from 22 investors (25% of the $20.3M target) as of the latest filing. Steve is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Other Health Care

SmartPharm Therapeutics, Inc.

Aspen, CO · Apr 8, 2019
  • Apr 8, 2019 · D · $10,527,003 sold of $10,527,003 · 27 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10.5M from 27 investors (100% of the $10.5M target) as of the latest filing. Steve is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Other Health Care

AperiSys, Inc.

Cumming, GA · Dec 4, 2015 → Jan 18, 2019 · 9 filings
  • Jan 18, 2019 · D/A · $680,000 sold of $1,000,000 · 8 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Jan 14, 2019 · D/A · $680,000 sold of $1,000,000 · 8 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Jan 11, 2019 · D · $680,000 sold of $1,000,000 · 8 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Dec 7, 2015 · D/A · $3,470,000 sold of $20,700,000 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 7, 2015 · D/A · $2,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 7, 2015 · D/A · $6,750 sold of $7,400 · 20 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 4, 2015 · D · $3,470,000 sold of $20,700,000 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 4, 2015 · D · $2,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 4, 2015 · D · $6,750 sold of $7,400 · 20 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $3.47M from 20 investors (100% of the $1M target) as of the latest filing. Steve is listed as executive officer, director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VL
Other Health Care

Vavotar Life Sciences LLC

Aspen, CO · Jan 5, 2016 → Jan 18, 2019 · 6 filings
  • Jan 18, 2019 · D · $10,000,000 sold of $10,000,000 · 31 investors · min. $6,250 · role: Executive Officer, Director EDGAR ↗
  • Sep 23, 2016 · D · $80,833,200 sold of $80,833,200 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 22, 2016 · D · $21,000,000 sold of $21,000,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 21, 2016 · D · $40,605,000 sold of $40,605,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 16, 2016 · D · $3,515,000 sold of $4,500,000 · 11 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 5, 2016 · D · $675 sold of $675 · 8 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $80.8M from 31 investors (100% of the $10M target) as of the latest filing. Steve is listed as executive officer, director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VL
Biotechnology

Vicapsys Life Sciences, Inc.

Sawanee, GA · Jan 8, 2018 → Feb 16, 2018 · 2 filings
  • Feb 16, 2018 · D · $50,000 sold of $6,000,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 8, 2018 · D · $0 sold of Indefinite · 52 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $470K from 52 investors (8% of the $6M target) as of the latest filing. Steve is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

P
Biotechnology

POLARITYTE, INC.

Salt Lake City, UT · Apr 10, 2017 → Sep 26, 2017 · 2 filings
  • Sep 26, 2017 · D · $17,750,002 sold of $17,750,002 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 10, 2017 · D · $1 sold of $1 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.8M from 28 investors (100% of the $17.8M target) as of the latest filing. Steve is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

O
Other Health Care

Ontrak, Inc.

Santa Monica, CA · Dec 31, 2014 → Jan 5, 2017 · 4 filings
  • Jan 5, 2017 · D · $5,562,796 sold of $5,562,796 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2015 · D · $3,553,030 sold of $3,553,030 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 30, 2015 · D · $2,121,212 sold of $2,121,212 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 31, 2014 · D · $1,100,000 sold of $1,100,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6.95M from 22 investors (100% of the $5.56M target) as of the latest filing. Steve is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HC
Other Health Care

H-CYTE, INC.

Tampa, FL · Apr 7, 2015 → May 3, 2016 · 2 filings
  • May 3, 2016 · D · $1,398,033 sold of $2,000,000 · 32 investors · min. $100,000 · role: Director (Co-Chairman) EDGAR ↗
  • Apr 7, 2015 · D · $0 sold of Indefinite · 92 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 92 investors (100% of the $2M target) as of the latest filing. Steve is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

GC
Other Health Care

Genomic Cancer Institute, Inc.

Tampa, FL · Jan 8, 2016
  • Jan 8, 2016 · D · $0 sold of $1,499,999 · 0 investors · min. $1 · role: Director EDGAR ↗

No sales reported yet as of the latest filing. Steve is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Biotechnology

ImmunityBio, Inc.

San Diego, CA · Jun 24, 2015 → Aug 5, 2015 · 3 filings
  • Aug 5, 2015 · D · $17,000,000 sold of $17,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2015 · D/A · $78,004,041 sold of $78,004,041 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 24, 2015 · D · $71,004,041 sold of $71,004,041 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $470M from 48 investors (100% of the $17M target) as of the latest filing. Steve is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

D
Pharmaceuticals

DemeRx, Inc.

Fort Lauderdale, FL · May 3, 2010 → May 8, 2015 · 6 filings
  • May 8, 2015 · D · $289,569 sold of $499,998 · 9 investors · min. $1,000 · role: Director EDGAR ↗
  • Mar 1, 2013 · D/A · $5,137,028 sold of $11,000,000 · 35 investors · min. $5 · role: Executive Officer, Director EDGAR ↗
  • Feb 27, 2013 · D/A · $5,137,028 sold of $11,000,000 · 35 investors · min. $5 · role: Executive Officer, Director EDGAR ↗
  • Sep 4, 2012 · D · $0 sold of $8,250,000 · 0 investors · min. $5 · role: Executive Officer, Director EDGAR ↗
  • Jun 21, 2010 · D · $0 sold of $15,000,000 · 0 investors · min. $2 · role: Executive Officer, Director EDGAR ↗
  • May 3, 2010 · D · $85 sold of Indefinite · 5 investors · min. $5 · role: Executive Officer, Director EDGAR ↗

Raised $5.14M from 35 investors (100% of the $500K target) as of the latest filing. Steve is listed as director, executive officer on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MG
Biotechnology

MIMEDX GROUP, INC.

Marietta, GA · May 1, 2009 → Nov 29, 2010 · 3 filings
  • Nov 29, 2010 · D · $2,080,000 sold of $5,000,000 · 20 investors · min. $5,000 · role: Director EDGAR ↗
  • Nov 19, 2009 · D · $675,000 sold of $5,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 1, 2009 · D · $1,420,000 sold of $4,025,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $4M from 20 investors (80% of the $5M target) as of the latest filing. Steve is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

C
Biotechnology

Celnyx, Inc.

Destin, FL · Aug 21, 2009
  • Aug 21, 2009 · D · $3,000,000 sold of $4,500,000 · 24 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗

Raised $3M from 24 investors (67% of the $4.5M target) as of the latest filing. Steve is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Steve Gorlin — NC, 1 issuer, Jan 31, 2012 → Jan 31, 2012 · no shared issuer

People around Steve 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Farrahar

Executive Officer, Director · 21 shared filings (5 issuers)

Charles Farrahar is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

John Thomas

Executive Officer, Director · 13 shared filings (5 issuers) · also on 10 other issuers

John Thomas is on 15 issuers in total — a repeat sponsor. Their page lists every one.

CK
No photo found yet (own website and image search run after this page is viewed)
Person

Charles E. Koob

Director, Executive Officer · 9 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

PP
No photo found yet (own website and image search run after this page is viewed)
Person

Parker H. Petit

Director, Executive Officer · 7 shared filings (3 issuers) · also on 2 other issuers

Parker H. Petit is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Hack

Director · 6 shared filings (2 issuers)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Edward J. Benz, Jr.

Director · 6 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey L. Raney

Executive Officer · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

TP
No photo found yet (own website and image search run after this page is viewed)
Person

Terren Peizer

Executive Officer, Director · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Martin A. Bell

Executive Officer · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Bert W. O'Malley

Director · 5 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Clifford C. Dasco, M.D.

Director, Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

David Lonard, PhD

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

LP
No photo found yet (own website and image search run after this page is viewed)
Person

Larry Papasan

Director · 5 shared filings (2 issuers)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Smith

Director · 4 shared filings (1 issuer) · also on 13 other issuers

David Smith is on 14 issuers in total — a repeat sponsor. Their page lists every one.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Richard A. Anderson

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

SE
No photo found yet (own website and image search run after this page is viewed)
Person

Susan Etzel

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

Henry Mellon

Director · 4 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

HW
No photo found yet (own website and image search run after this page is viewed)
Person

Holger Weis

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jesse W. Crowne

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

WP
No photo found yet (own website and image search run after this page is viewed)
Person

William Haseltine, PhD.

Director · 4 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan W. Simons

Director · 4 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Berman

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Richard Berman is on 5 issuers in total — a repeat sponsor. Their page lists every one.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Soon-Shiong

Director · 3 shared filings (1 issuer) · also on 19 other issuers

Patrick Soon-Shiong is on 20 issuers in total — a repeat sponsor. Their page lists every one.

KE
No photo found yet (own website and image search run after this page is viewed)
Person

Kurt M Eichler

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Deborah C. Mash, Ph.D.

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Steven M. Paul, M.D.

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew K. Rooke

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

HD
No photo found yet (own website and image search run after this page is viewed)
Person

Henry Ji, Ph.D.

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence Friedhoff, M.D., Ph.D., FACP

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

E. Douglas Kramer

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Rosen

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Kusserow

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Gomberg

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Barry J. Simon, M.D.

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Soon-Shiong, M.D.

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

John T. Potts, Jr., M.D.

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

MI
No photo found yet (own website and image search run after this page is viewed)
Person

Marvin Igelman

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jon Mogford

Director, Executive Officer · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

LD
No photo found yet (own website and image search run after this page is viewed)
Person

Lee Fleisher, M.D.

Director · 3 shared filings (1 issuer)

Listed on the same filings as Steve Gorlin. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Miller

Executive Officer, Director · 3 shared filings (2 issuers) · also on 6 other issuers

Matthew Miller is on 8 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 15 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Steve Gorlin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 15 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Steve Gorlin is listed on: none on file. No website or social profile named in ImmunityBio, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #116,251 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗Georgia state courts — find the court ↗California — find the county court ↗Los Angeles Superior Court case search ↗Colorado state courts — find the court ↗New Jersey state courts — find the court ↗Utah state courts — find the court ↗Minnesota court records online ↗Clark County NV District Court portal ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Florida Secretary of State business search ↗Georgia Secretary of State business search ↗California Secretary of State business search ↗Colorado Secretary of State business search ↗New Jersey Secretary of State business search ↗Utah Secretary of State business search ↗Minnesota Secretary of State business search ↗Nevada Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Steve Gorlin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →